首页> 外文期刊>Biomaterials >Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice.
【24h】

Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice.

机译:在小鼠中异位骨诱导和重组人骨形态发生蛋白2负载的多孔β-磷酸三钙的早期降解。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study investigated the ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2 (rhBMP-2)-loaded porous beta-tricalcium phosphate (beta-TCP) in mice. The porous beta-TCP with 50mug of rhBMP-2 (n=25) and porous beta-TCP (control group, n=25) were implanted into muscle pouches in the right and left thigh of 28-day-old mice (n=25), respectively. At every time point (3, 7, 14, 21 and 28 days after implantation), five mice were euthanized and the histological examinations of implantation sites were performed. In addition, the alkaline phosphatase (ALP) activity was also quantitatively analyzed. For the rhBMP-2-loaded group, blood vessel formation and immature cartilage was observed within the porous beta-TCP 3 days after implantation. Mature cartilage was observed 7 days after implantation of rhBMP-2-loaded porous beta-TCP. Newly formed woven bone, lamellar bone as well as marrow were observed 14 and 21 days after implantation of the rhBMP-2-loaded porous beta-TCP. Lamellar bone and marrow were observed 28 days after implantation of the rhBMP-2-loaded porous beta-TCP. For the control group, no bone or cartilage was observed at all time points. However, multinucleated giant cells and fibrous tissues were observed in the control group at 7 and 28 days after implantation, respectively. At 21 and 28 days after implantation, porous beta-TCP was observed to fragment indicating early degradation of the porous beta-TCP in both groups. In addition, ALP was observed to be significantly higher in the rhBMP-2-loaded beta-TCP as compared to the control beta-TCP. It was concluded from this study that the rhBMP-2-loaded porous beta-TCP induced blood vessel and ectopic bone formation.
机译:本研究调查了异位骨诱导和重组人骨形态发生蛋白2(rhBMP-2)加载多孔β-磷酸三钙(β-TCP)的早期降解。将具有50mug rhBMP-2的多孔β-TCP(n = 25)和多孔β-TCP(对照组,n = 25)植入28日龄小鼠左右大腿的肌肉袋中(n = 25)。在每个时间点(植入后3、7、14、21和28天),对5只小鼠实施安乐死并进行植入部位的组织学检查。另外,还定量分析了碱性磷酸酶(ALP)的活性。对于负载rhBMP-2的组,植入后3天在多孔β-TCP中观察到血管形成和未成熟软骨。植入rhBMP-2的多孔β-TCP植入7天后观察到成熟的软骨。植入rhBMP-2的多孔β-TCP植入后14天和21天,观察到新形成的编织骨,层状骨以及骨髓。植入rhBMP-2的多孔β-TCP植入28天后,观察到了片状骨和骨髓。对于对照组,在所有时间点均未观察到骨骼或软骨。然而,对照组分别在植入后7天和28天观察到多核巨细胞和纤维组织。在植入后21和28天,观察到多孔的β-TCP断裂,表明两组中的多孔的β-TCP较早降解。另外,与对照β-TCP相比,在负载有rhBMP-2的β-TCP中观察到ALP显着更高。从这项研究得出的结论是,负载rhBMP-2的多孔β-TCP诱导了血管和异位骨的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号